Meningitis and Encephalitis in the Intensive Care Unit

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3197 times

Chapter 34 Meningitis and Encephalitis in the Intensive Care Unit

Meningitis

5 What are the most common causes of community-acquired acute bacterial meningitis in adults?

Table 34-2 includes the most common organisms in descending order based on case series with preferred antimicrobial therapy and suggested duration of treatment.

Table 34-2 Most Common Causes of Community-Acquired Bacterial Meningitis in Adults

Pathogens Preferred antimicrobial Suggested duration of therapy
S. pneumoniae
PCN MIC < 0.1 mcg/mL
PCN MIC 0.1-1 mcg/mL
PCN MIC  2 mcg/mL
PCN or ampicillin
Third-generation cephalosporin
Vancomycin + third-generation cephalosporin
10-14 days
N. meningitidis
PCN MIC < 0.1 mcg/mL
PCN MIC > 0.1 mcg/mL
PCN or ampicillin
Third-generation cephalosporin
7 days
L. monocytogenes Ampicillin or PCN  21 days
Streptococcus agalactiae, pyogenes Ampicillin or PCN 21 days
S. aureus MSSA → nafcillin, oxacillin
MRSA → vancomycin
14 days
H. influenzae
β-Lactamase negative
β-Lactamase positive
Ampicillin
Third-generation cephalosporin
7 days

MIC, Minimum inhibitory concentration; MSSA, methicillin-sensitive S. aureus; PCN, penicillin.

6 What is adequate empirical therapy while awaiting culture results?

Empirical therapy should reflect suspected pathogens on the basis of host factors as well as local antibiotic susceptibility patterns. For example, Streptococcus pneumoniae is commonly known to have resistance to penicillin. Some strains are also resistant to third-generation cephalosporins. As a result, empirical therapy for S. pneumoniae should include high-dose third-generation cephalosporin as well as vancomycin. Empirical therapy with third-generation cephalosporin is also suggested for Neisseria meningitidis. For Listeria monocytogenes, preferred treatment is ampicillin, although trimethoprim-sulfamethoxazole is another option if the patient is penicillin allergic. Thus in an adult older than 50 years, an initial empirical regimen including vancomycin, high-dose ceftriaxone, and ampicillin would be suggested to treat the most likely community-acquired pathogens.

In the event that a patient has undergone recent neurosurgical instrumentation and has risk for nosocomial pathogens, one would also want to include therapy directed at methicillin-resistant Staphylococcus aureus (MRSA) and resistant nosocomial gram-negative bacilli, such as Pseudomonas aeruginosa.

Risk factors that may additionally influence empiricism must be identified with each patient. Prompt and detailed history should be explored. Factors including exposures, such as contaminated food consumption, travel, and sick contacts should be identified. Presence of immune suppression should also be elicited. The type and degree of immune suppression, including medications, absence of spleen, advanced HIV, and administration of chemotherapy should be sought. Risk factors for nosocomial pathogens, including recent neurosurgical procedures, presence of a foreign body within the CNS (such as a ventricular drain), and trauma are also important to determine, as noted earlier.

11 What CSF studies are important?

A number of guides help determine likelihood for bacterial meningitis based on various CSF markers, although it is important to know that none are absolute. See Table 34-3 for specific indicators.

A positive Gram stain confirms bacterial meningitis. However, culture data remain important for speciation (especially if morphology is not characteristic) and antimicrobial sensitivities. Low glucose level can be very helpful in indicating acute bacterial meningitis, but it is important to remember that other factors can contribute to a low glucose finding. For example, Mycobacterium tuberculosis meningitis, which is typically chronic, is commonly associated with low CSF glucose level. Malignancies are also associated with low CSF glucose level.

In addition, other tests have been studied to improve performance when trying to distinguish bacterial versus nonbacterial causes of meningitis. One such marker, CSF lactate, was shown to add predictive value when trying to distinguish between bacterial meningitis and nonbacterial meningitis shortly after neurosurgery. In a study of patients after neurosurgery by Lieb and colleagues, a cutoff of 4 mmol/L CSF lactate was 88% sensitive and 98% specific for diagnosis of bacterial meningitis. Of interest, CSF lactate levels did not vary with the presence or absence of red blood cells (RBCs), nor was there a correlation with days after surgery.

Encephalitis

19 What should the initial diagnostic work-up include?

After careful history and physical examination, neuroimaging is recommended. This can suggest possible causes, dependent on regions of involvement, and may also exclude other possible causes, such as brain abscess. The most sensitive neurologic imaging is magnetic resonance imaging (MRI). If MRI cannot be performed, CT with contrast is the next preferred method. CSF evaluation is also suggested, unless contraindicated. CSF studies should include the usual cell count with differential, protein, and glucose markers. CSF should be sent for PCR evaluation for HSV and enteroviruses. A positive test is helpful, but a negative first test does not exclude infection if the clinical suspicion is high. Repeated testing within 3 to 7 days is suggested. Of note, the presence of hemoglobin can interfere with HSV PCR and cause a false negative result. PCR can also be performed to evaluate for VZV and CMV. If acute HIV is considered, one would need to obtain serum quantification of HIV RNA levels, because initial antibody testing may be negative. CSF cultures have not been helpful in elucidating viral causes but should be obtained if concern exists for nonviral causes, including bacteria and fungal organisms. Brain biopsy is usually reserved for those cases in which initial evaluation has been unrevealing and the patient continues to have clinical decline.

Additional studies should be obtained in the context of a patient’s epidemiologic risks. For example, travel to endemic areas could heighten concern for rickettsial disease or flaviviruses. An animal bite, particularly in a developing nation, could increase suspicion for rabies.

Bibliography

1 Attia J., Hatala R., Cook D., et al. Does this adult patient have acute meningitis? JAMA. 1999;281:175–181.

2 Durand M., Calderwood S., Weber D., et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993;328:21–28.

3 Gans J.D., Van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549–1556.

4 Hasbun R., Abrahams J., Jekel J., et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345:1727–1733.

5 Leib S., Boscacci R., Gratzl O., et al. Predictive value of cerebrospinal fluid (CSF) lactate levels versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999;29:69–74.

6 Lepper M.H., Dowling H.F. Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin. AMA Arch Intern Med. 1951;88:489–494.

7 Mayefsky J.F., Roghmann K.J. Determination of leukocytosis in traumatic spinal tap specimens. Am J Med. 1987;82:1175–1181.

8 Sawyer M.H., Rotbart H.A. Viral meningitis and aseptic meningitis syndrome. In: Scheld W.M., Whitley R.J., Marra C.M. Infections of the Central Nervous System. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:75–93.

9 Tunkel A.R., Glaser C.A., Bloch C.B., et al. The management of encephalitis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis. 2008;47:303–327.

10 Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–1284.

11 Tunkel A.R., Van de Beek D., Scheld W.M. Acute meningitis. In: Mandell G., Bennett J., Dolin R. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010:1189–1229.